Dupixent

I had the opportunity to bring the blockbuster drug, Dupixent, to the global market across all channels. In addition to Atopic Dermatitis (AD), my team shaped the brand for new indications Prurigo Nodularis (PN), and Chronic Spontaneous Urticaria (CSU) with great launch success. Providing the creative approach, brand guidance, and global oversight for Dupixent with agency partners and franchise clients; Brazil, Canada, China, France, Germany, Italy, Japan, Mexico, Netherlands, Spain, UK, and the US.

My Role: Global Associate Creative Director, Designer, Brand Strategy